scispace - formally typeset
J

Javier P. Gisbert

Researcher at Autonomous University of Madrid

Publications -  1076
Citations -  39753

Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.

Papers
More filters
Journal ArticleDOI

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

TL;DR: The prevalence of malnutrition in inflammatory bowel disease patients was high and some predictive factors of malnutrition were identified, including history of abdominal surgery, active disease and avoidance of some foods during flares were associated with higher risk of malnutrition.
Journal ArticleDOI

Meta‐analysis: comparative efficacy of different proton‐pump inhibitors in triple therapy for Helicobacter pylori eradication

TL;DR: This data indicates that proton‐pump inhibitors used in triple therapy for Helicobacter pylori eradication may be more efficacious than other proton-pumps used in this type of therapy.
Journal ArticleDOI

Liver injury in inflammatory bowel disease: Long‐term follow‐up study of 786 patients

TL;DR: In IBD patients, AZA or MP treatment induces abnormality of LTs in a relatively high proportion of the cases, but the development of true hepatotoxicity/liver injury is exceptional.
Journal ArticleDOI

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

TL;DR: Non-tumor necrosis factor drugs can cross the placenta from the latter part of the second trimester of gestation, although they seem to be safe, at least in the short term.
Journal ArticleDOI

European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

TL;DR: Management of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations, which is associated with an overall effectiveness increase.